A similar difference in the crb3 expression level existed among MS and control groups (p-value: 0.04, Fig. 3d), though it was not statistically significant in the TAZ gene expression (p-value: 0.30, Fig. 3b). Here, CRB3 is linked to myeloid sarcoma.